| Drug Name |
Sevelamer carbonate |
| Drug ID |
BADD_D02013 |
| Description |
Sevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. It is marketed by Genzyme under the trade name Renagel. |
| Indications and Usage |
For the control of serum phosphorus in patients with Chronic Kidney Disease (CKD) on hemodialysis. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
V03AE02 |
| DrugBank ID |
DB00658
|
| KEGG ID |
D06642
|
| MeSH ID |
D000069603
|
| PubChem ID |
11593706
|
| TTD Drug ID |
D03MZQ
|
| NDC Product Code |
0955-1052; 16571-739; 65862-930; 65862-923; 17856-0921; 58468-0131; 70518-2490; 16714-814; 0955-1050; 55154-8188; 43826-139; 72643-013; 68382-824; 0904-6707; 60687-328; 65977-0078; 76339-144; 55111-789; 72969-101; 62147-0187; 0115-1366; 66499-0023; 50268-720; 65162-058; 70771-1520; 69452-126; 65015-748; 65862-931; 76282-664; 0115-1365; 69680-143; 65862-921; 58468-0132; 0955-1054; 71205-966; 0615-8239; 55154-3358; 69097-967; 69452-127; 58468-0130; 69097-893; 76282-407; 67787-407; 68094-034; 24979-186 |
| Synonyms |
Sevelamer | GT335-012 | GT335 012 | GT335012 | Sevelamer Hydrochloride | Hydrochloride, Sevelamer | RenaGel | Sevelamer Carbonate | Carbonate, Sevelamer |
